6505--PET Prostate-Specific Membrane Antigen Radiopharmaceuticals

Solicitation / RFP / RFQ

This is a combined synopsis/solicitation (RFQ) for the provision of unit dose Positron Emission Tomography (PET) radiopharmaceuticals for diagnostic patient care, specifically for prostate cancer imaging. The Department of Veterans Affairs (VA), Network Contracting Office 12 (NCO 12), requires these pharmaceuticals for the Jesse Brown VA Medical Center in Chicago, IL. Due to the short shelf life (<6 hours) of these products, local production and delivery are essential. The VA intends to award a firm-fixed-price contract.

• Provision of FDA-approved Prostate-Specific Membrane Antigen (PSMA) targeted radiopharmaceuticals in unit doses.

• Daily routine deliveries (Monday-Friday) based on patient schedules; no routine weekend deliveries.

• Contractor must maintain proximity (preferably within 30 miles) to Jesse Brown VA Medical Center for urgent requests.

• Products must be properly labeled with calibrated activity, expiration, lot number, and hazard markings.

• Packaging must meet federal/state regulations and be clearly labeled RADIOACTIVE.

• Compliance with Nuclear Regulatory Commission (NRC), Department of Transportation (DOT), Food and Drug Administration (FDA), and United States Pharmacopeia Chapter 825 (USP <825>) guidelines.

• Maintenance of an Illinois Emergency Management Agency (IEMA) license.

• Performance of Quality Control testing per USP <825>.

• A specific item is listed: F-18 PSMA Imaging Radiopharmaceutical, 9 mCi, Unit Dose, with an estimated annual quantity of 205.

• Unused dose fee policy: VA may request an unused dose fee of $450 if unused dose is due to patient no-show/cancellation and requested by 8:00 PM ET next business day.

• Contract Type: Firm-fixed-price.

• Period of Performance: February 1, 2026 – January 31, 2027 (12 months).

• Place of Performance: Jesse Brown VA Medical Center, 820 S. Damen Avenue, Chicago, IL 60612-422.

• Submission Deadline: January 26, 2026, 5:00 PM Eastern Time.

• Submission Method: Email to Stacy.Massey@va.gov.

• Evaluation Factors: Technical Acceptability (Pass/Fail based on PWS compliance), Delivery Reliability, Past Performance, and Price.

• Award will be made to the most advantageous offer, considering price and other factors. Technical proposals are evaluated on a Pass/Fail basis.

• Offerors must demonstrate compliance with all PWS requirements, delivery capabilities, relevant experience, and provide a completed Price Cost Schedule.

• Offerors must hold an active Federal Government contracts registration in the System for Award Management (SAM).

• This acquisition is unrestricted.

• NAICS Code: 325412 (Pharmaceutical Preparation Manufacturing) with a small business size standard of 1,300 employees.

• FSC/PSC Code: 6505 (Drugs and Biologicals).

• The solicitation incorporates numerous FAR and VAAR provisions and clauses by reference. Full text is available at www.acquisition.gov.

• Questions should be submitted in writing via email to the Contracting Officer.

• Offerors must hold an active SAM registration.

• Offerors agree to hold prices firm for 60 calendar days from the receipt date.